The national health insurance landscape in the United States has undergone major changes in 2025 following the enactment of the “One Big Beautiful Bill Act” (OBBB), signed into law by President Trump on July 4, 2025[1]. The law, which passed after considerable debate in Congress, makes extensive cuts to federal health programs including Medicaid, Medicare, and provisions under the Affordable Care Act (ACA), resulting in a projected increase of 10 million uninsured Americans and more than $1 trillion in reduced federal health care spending[1].
Key Provisions and Impacts:
- Medicaid cuts and new requirements: OBBB introduces work or “community engagement” requirements for certain adults to maintain Medicaid eligibility, imposes more frequent eligibility checks, and tightens restrictions on groups such as some lawfully present immigrants. States face new limits in generating additional Medicaid funds, which are expected to contribute significantly to overall coverage losses[3].
- Affecting Affordable Care Act Marketplace: Financial assistance for purchasing ACA insurance will end after 2025. This change alone is estimated to result in 5 million more uninsured, further accelerating coverage losses across the entire system[3].
- Medicare eligibility restrictions for immigrants: Starting immediately, only U.S. citizens, lawful permanent residents, certain Cuban and Haitian entrants, and individuals from specific Pacific island nations can newly enroll in Medicare. Other lawfully present immigrants, including refugees and asylees, will no longer qualify, with coverage for current beneficiaries in these categories ending January 2027[3].
- Nursing home staffing requirements blocked: The law prevents new national minimum staffing rules for nursing homes from taking effect[3].
- Prescription drug negotiation scaled back: The law excludes orphan drugs (those for rare diseases) from Medicare’s drug price negotiation authority, limiting the program’s ability to restrain costs for high-priced medications[3].
- Medical cost trends: Despite cuts, medical inflation remains high, with group market costs projected to rise 8.5% and individual market costs 7.5% for 2026. Individual Coverage Health Reimbursement Arrangements (ICHRAs)—employer-funded allowances for ACA-compliant plans—are growing in popularity, as are efforts to provide clearer, more predictable insurance options[5].
- Price transparency and oversight: Enforcement of Centers for Medicare and Medicaid Services (CMS) pricing transparency rules continues, with hospitals and insurers increasingly publishing their price data online. While transparency could eventually help contain costs, implementation is inconsistent and data quality remains a challenge[5].
Uncertainties Remain: Policy direction for future executive actions and additional congressional proposals remains unclear, with debate ongoing about further changes to Medicaid, Medicare, and the ACA. Broader issues—including prescription drug costs, public health funding, and reproductive rights—are also poised for legislative attention in the near future[2].